Evidence map›Paper›PMID 35652962›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2022

A comparison of advanced semi-quantitative amyloid PET analysis methods.

Enrico Peira, Davide Poggiali, Matteo Pardini, Henryk Barthel, Osama Sabri, Silvia Morbelli, Annachiara Cagnin, Andrea Chincarini, Diego Cecchin

Open access · hybridAbstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Comparison of Amyloid-PET Analysis Software UsingDiagnostics (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Enrico PeiraINFN - National Institute of Nuclear Physics, via Dodecaneso 33, 16146, Genoa, Italy. enrico.peira@gmail.com.ORCID 0000-0002-5834-8101
Davide PoggialiPNC - Padua Neuroscience Center, University of Padua, Padua, Italy.
Matteo PardiniDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Child and Maternal Health (DINOGMI), University of Genoa, Genoa, Italy.
Henryk BarthelDepartment of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany.
Osama SabriDepartment of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany.
Silvia MorbelliIRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Annachiara CagninNeurology Unit, Department of Neurology, University Hospital of Padua, Padua, Italy.
Andrea ChincariniINFN - National Institute of Nuclear Physics, via Dodecaneso 33, 16146, Genoa, Italy.
Diego CecchinPNC - Padua Neuroscience Center, University of Padua, Padua, Italy.
University of Padua · ITIstituto Nazionale di Fisica Nucleare, Sezione di Genova · ITOspedale Policlinico San Martino · ITUniversity Hospital Leipzig · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo date, there is no consensus on how to semi-quantitatively assess brain amyloid PET. Some approaches use late acquisition alone (e.g., ELBA, based on radiomic features), others integrate the early scan (e.g., TDr, which targets the area of maximum perfusion) and structural imaging (e.g., WMR, that compares kinetic behaviour of white and grey matter, or SI based on the kinetic characteristics of the grey matter alone). In this study SUVr, ELBA, TDr, WMR, and SI were compared. The latter - the most complete one - provided the reference measure for amyloid burden allowing to assess the efficacy and feasibility in clinical setting of the other approaches.

methodsWe used data from 85 patients (aged 44-87) who underwent dual time-point PET/MRI acquisitions. The correlations with SI were computed and the methods compared with the visual assessment. Assuming SUVr, ELBA, TDr, and WMR to be independent measures, we linearly combined them to obtain more robust indices. Finally, we investigated possible associations between each quantifier and age in amyloid-negative patients.

resultsEach quantifier exhibited excellent agreement with visual assessment and strong correlation with SI (average AUC = 0.99, ρ = 0.91). Exceptions to this were observed for subcortical regions with ELBA and WMR (ρ

conclusionAmong the other methods, TDr came closest to the reference with less implementation complexity. Moreover, this study suggests that combining independent approaches gives better results than the individual procedure, so efforts should focus on multi-classifier systems for amyloid PET. Finally, the ability of techniques integrating blood perfusion to depict age-related variations in amyloid load in amyloid-negative subjects demonstrates the goodness of the estimate.

Indexed as

Alzheimer DiseaseAmyloidosisAmyloidAmyloid beta-PeptidesAniline CompoundsBrainHumansMagnetic Resonance ImagingPositron-Emission TomographyAmyloidAmyloid beta-PeptidesAniline CompoundsAge-related amyloidAmyloid PETDual time pointQuantificationRegional amyloid

Identifiers

PMID35652962
PMCPMC9525368
OpenAlexW4281855831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.